LivingGLP1
Study S002759

A Bioequivalence Study of HS-20094 Multi-dose Pre-filled Injection and HS-20094 Single-dose Pre-filled Injection in Overweight or Obese Participants

Registration

Registration
NCT07057674
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
NONE
Status
RECRUITING
Enrollment
144
Start
2025-04-16
Primary completion
2026-02-04
Lead sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Overweight or Obesity
Interventions
DRUG:HS-20094 AI pen;; DRUG:HS-20094 MDV pen
Results posted
FALSE

Registered primary outcomes

  • To evaluate the bioequivalence of HS-20094 MDV pen and AI pen following multiple doses at 15 mg. [From Day 1 to Day 169]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.